Germany's Bundeskartellamt approves planned acquisition of CureVac by BioNTech ($5.39, 0.00)
Acting Director of CDC approves changes to the adult and child immunization schedules
Next ACIP meeting could be pushed to December - Endpoints News
Powered by FactSet Research Systems Inc.